Ivermectin Dosage Chart for Humans by Indication and Reference Label
Condition-specific reference tables explain why weight, tablet strength and follow-up all matter.
Reference table
Ivermectin reference table
The US label describes a single oral dose designed to provide approximately 200 mcg/kg, taken on an empty stomach with water. The table reproduces the label's tablet-count bands for an educational reference. It does not create a personal prescription. For onchocerciasis, the US STROMECTOL label describes approximately 150 mcg/kg as a single oral dose. The follow-up interval and need for retreatment are part of the clinical plan. The weight bands differ from those in the strongyloidiasis table.
US STROMECTOL reference for strongyloidiasis
| Body weight | Number of 3 mg reference tablets |
|---|---|
| 15–24 kg | 1 |
| 25–35 kg | 2 |
| 36–50 kg | 3 |
| 51–65 kg | 4 |
| 66–79 kg | 5 |
| 80 kg or more | 200 mcg/kg calculated by the clinician |
US STROMECTOL reference for onchocerciasis
| Body weight | Number of 3 mg reference tablets |
|---|---|
| 15–25 kg | 1 |
| 26–44 kg | 2 |
| 45–64 kg | 3 |
| 65–84 kg | 4 |
| 85 kg or more | 150 mcg/kg calculated by the clinician |
The source product and country are identified in the article. Confirm personal treatment instructions with the prescribing clinician.
What the reference charts cover
The US STROMECTOL label covers oral treatment of intestinal strongyloidiasis and onchocerciasis. Its weight bands belong to those conditions and that 3 mg reference tablet. Weight in kilograms and dose units must remain visible when reading the table.
CDC's strongyloidiasis guidance describes first-line ivermectin treatment and separate care for severe infection. Immunosuppression, pregnancy, breastfeeding, possible Loa loa infection and weight below 15 kg need specific clinical consideration. The treating team decides whether a standard reference applies.
US STROMECTOL reference for strongyloidiasis
The US label describes a single oral dose designed to provide approximately 200 mcg/kg, taken on an empty stomach with water. The table reproduces the label's tablet-count bands for an educational reference. It does not create a personal prescription.
Follow-up stool examinations help establish clearance. CDC also discusses treatment duration and follow-up in its clinical guidance, so clinicians should reconcile the relevant product label and current practice guidance.
US STROMECTOL reference for onchocerciasis
For onchocerciasis, the US STROMECTOL label describes approximately 150 mcg/kg as a single oral dose. The follow-up interval and need for retreatment are part of the clinical plan. The weight bands differ from those in the strongyloidiasis table.
Symptoms and circumstances to discuss
Tell the treating clinician about travel or residence in areas where Loa loa occurs, immune-suppressing treatment, pregnancy and breastfeeding. CDC recommends follow-up examinations after treatment in selected patients with persistent symptoms and positive stool findings.
Seek urgent help for a severe reaction or neurological symptoms such as marked confusion, unusual drowsiness or loss of coordination. A suspected overdose needs prompt medical assessment. Bring the pack so the actual ingredient and strength can be identified.
Tell your clinician about travel and steroid treatment
If Strongyloides is being considered, mention where you have lived or travelled, even if that was years ago. Tell the clinician if you take a medicine that suppresses your immune system or are due to start corticosteroids. The CDC identifies these situations as reasons to consider screening because an otherwise quiet Strongyloides infection can become severe with immune suppression.
Bring the name and start date of any steroid and contact the team that prescribed it so they can coordinate with the clinician evaluating the parasite. The prednisolone steroid guide explains what details to bring to that discussion. Exposure in parts of West or Central Africa is also important because possible Loa loa infection can change the safety assessment before ivermectin.
Know whether you need to repeat a test
Ask which result confirmed the infection, whether your test needs repeating, and when the next review is due. For confirmed strongyloidiasis, CDC guidance calls for a follow-up stool examination two to four weeks after treatment when the initial stool test was positive and symptoms continue. The clinician can make a different follow-up plan based on how the infection was diagnosed.
Keep a copy of your original report and record the dates the doses were taken. If symptoms persist, give the clinician that timeline and ask whether to repeat a test, review the diagnosis, or check for a complication before taking any more medicine.
Matching the exact tablet before a supply enquiry
GME lists Iverheal 3, Iverheal 6, Ivermaxx-12 and Ivermaxx-20 presentations. Keep the strength attached to the brand in an enquiry. A fixed combination also contains another ingredient and requires its own prescribed-product assessment.
Send the ingredient, strength, tablet count, destination and manufacturer preference when requesting product information. Ask which exact label, batch and commercial records can accompany the offered pack. Human and veterinary presentations must be identified clearly, and destination eligibility requires independent confirmation.
View Ivermectin 3 mg Tablets, Ivermectin 6 mg Tablets, Ivermectin 12 mg Tablets and Ivermectin 20 mg Tablets for the listed product information.
Export product support
Need product, pack, and documentation details?
Global Medicines Export can support international B2B enquiries for product availability, strengths, pack information, quotation coordination, and shipment documentation review.
Common questions
Can the table be read as a 12 mg tablet schedule?
Its counts specifically refer to 3 mg STROMECTOL tablets. A clinician or pharmacist must reconcile the prescribed amount with the exact product.
Why are there two weight charts?
They belong to different parasitic infections in the US reference label.
Can symptoms alone identify which chart applies?
A healthcare professional needs to establish the infection and assess relevant risks and testing.
What information helps with a product enquiry?
Give the precise ingredient, tablet strength, quantity, destination and the manufacturer or brand required by the prescription.
I am due to start prednisone or prednisolone. Who should I tell about possible Strongyloides exposure?
Tell the team prescribing the steroid and give them your travel, residence and test history. Ask them to coordinate any screening or treatment. Keep taking prescribed medicines as directed while you seek their advice.
Are veterinary ivermectin products equivalent to human prescriptions?
They are different products. The US FDA warns that animal products can be highly concentrated and have ingredients that have only been assessed for the intended animal use. Ask a clinician or pharmacist about the exact human product on your prescription.
Important medical note
This article is for general educational information only. It is not medical advice, diagnosis, or a treatment plan. Medicines should be used only under the guidance of a qualified healthcare professional. Product availability, export documentation, and quotation support do not imply that a medicine is appropriate for any individual patient.